Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

4 clinical studies listed.

Filters:

Nail Psoriasis

Tundra lists 4 Nail Psoriasis clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT06578728

Local Methotrexate Injections for the Treatment of Nail Psoriasis

The investigators hope to learn the efficacy of methotrexate injections for treatment of nail psoriasis.

Gender: All

Ages: 18 Years - Any

Updated: 2026-03-25

1 state

Nail Psoriasis
NOT YET RECRUITING

NCT07313072

Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study

To evaluate the efficacy and safety of topical 2% tofacitinib nail lacquer in nail psoriasis, using the NAPSI and DLQI scales before and after 26 weeks of treatment.

Gender: All

Ages: 18 Years - Any

Updated: 2026-03-18

Nail Psoriasis
RECRUITING

NCT07029516

Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis

A randomized, double blind, placebo-controlled, unicenter, parallel group study to assess the efficacy, safety and tolerability of a multi-funtion toe nail patch in patients affected by nail fragility, nail mychosis and psoriasis 72 patients in 6 subgroups Treatment duration 3 months + 1 month follow-up

Gender: All

Ages: 18 Years - Any

Updated: 2026-01-26

Nail Psoriasis
Nail Damage
Mycosis
NOT YET RECRUITING

NCT06802848

Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)

Xeligekimab Injection was approved in China on August 20, 2024, for treating adults with moderate to severe plaque psoriasis who are candidates for systemic treatment or phototherapy. Despite the promising efficacy and safety shown in the phase III clinical trial, real-world data is needed to further support clinical decisions for this patient group. This study aims to evaluate the effectiveness and safety of xeligekimab in real-world clinical settings for adults with moderate to severe plaque psoriasis.

Gender: All

Ages: 18 Years - Any

Updated: 2025-01-31

1 state

Plaque Psoriasis
Psoriatic Arthritis
Scalp Psoriasis
+3